Extrait

This study will test the effectiveness and safety of two doses of solabegron against placebo in reducing the symptoms of overactive bladder.

Critère d'inclusion

• Overactive Bladder

Pays

• Argentina
• Australia
• Finland
• France
• Germany
• Korea, Republic of
• Latvia
• Netherlands
• New Zealand
• Poland
• Slovenia
• South Africa
• Spain
• Taiwan, Province of China

Liens

• ictrp
• nct